Inpatient Update

Bölümler

• 
  Rethinking ABGs, GNR bacteremia & Steroid Leukocytosis — JHM Wrapped 2025 12.08.2026 36dk

  With Special Guests Dr. Catie Glatz & Dr. Joseph S. Thomas In this special episode of Inpatient Update, Dr. Mason Turner is joined by Dr. Catie Glatz and Dr. Joseph S. Thomas of the Journal of Hospital Medicine Digital Media Team to dig into three practice-changing articles featured in #JHMWrapped 2025 — JHM’s annual roundup of some of the year’s most impactful hospital medicine literature: Gram-negative bacteremia — if Cipro and Bactrim aren’t options, does your patient really need conti...
• 
  News Flash: Cyclospora Outbreak — What Hospitalists Need to Know 24.07.2026 26dk

  With Special Guest Dr. Scott Curry In this Inpatient Update News Flash, Dr. Mason Turner is joined by infectious disease physician and hospital epidemiologist Dr. Scott Curry to examine the sharp rise in cyclosporiasis cases across the United States—and what it should change in clinical practice. Thousands of confirmed cases have been reported across more than 40 states, with hundreds of hospitalizations and additional clusters still under investigation. So what should hospitalists do differe...
• 
  Don’t Leave Fluids on Autopilot: Pancreatitis and LR vs Normal Saline 02.07.2026 25dk

  In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Daniel Hardgrove to rethink two common fluid decisions: Acute pancreatitis — should aggressive IV fluids still be the default?LR vs normal saline — does balanced crystalloid actually improve outcomes?Practical take-homes, real-world discussion, and what to change on rounds tomorrow. Articles & PubMed Links Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis New England Journal of Medicine, 20...
• 
  Semi-Annual Takeaways: 5 Practice-Changing Updates for Hospitalists 18.06.2026 33dk

  Semi-Annual Recap Episode In this special episode of Inpatient Update, Dr. Mason Turner looks back at the first 10 episodes and distills the biggest practice-changing lessons from more than 25 recent studies. If you're new to the show, this is the fastest way to understand what Inpatient Update is all about: practical evidence that changes what hospitalists do on rounds tomorrow. From pneumonia treatment and antibiotic duration to anticoagulation, flu vaccination, and asymptomatic inpatient h...
• 
  Too Cautious? Rethinking Hyponatremia Correction and DVT Prophylaxis 04.06.2026 40dk

  With Special Guest Dr. Bianca Farley In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Bianca Farley to examine two practices driven largely by fear of rare but devastating complications: Are we correcting severe hyponatremia too cautiously? Does pharmacologic DVT prophylaxis improve outcomes that actually matter to patients? Two common hospitalist decisions. Two deeply ingrained habits. Two areas where the evidence may be more nuanced than many of u...
• 
  Shorter CAP Antibiotics + The Cipro QTc Myth 20.05.2026 27dk

  With Special Guest Dr. Ernest Murray In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Ernest Murray to challenge two common antibiotic reflexes in hospital medicine: Do hospitalized patients with community-acquired pneumonia really need 5–7 days of antibiotics?Do we need to panic about QT prolongation every time we prescribe ciprofloxacin?Two everyday prescribing decisions. Two long-standing assumptions. Two areas where the evidence may support a more precise...
• 
  Fewer Bleeds, Smarter Steroids: Apixaban vs Rivaroxaban and CRP-Guided Steroids for Pneumonia 06.05.2026 27dk

  With Special Guest Dr. Adam Jaffe In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Adam Jaffe to tackle two high-impact clinical questions: Is there a clear winner among DOACs? Who actually benefits from steroids in community-acquired pneumonia? Two common decisions. New data. Practice-changing implications. Articles & PubMed Links Apixaban vs Rivaroxaban for VTE (Head-to-Head RCT) New England Journal of Medicine (2026) Randomized trial (n...
• 
  Asymptomatic Hypertension & Viral Pneumonia — Stop Overtreating 22.04.2026 29dk

  With Special Guest Dr. Austin White In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Austin White to tackle two everyday controversies that affect nearly every admission: Asymptomatic inpatient hypertension — are PRN antihypertensives helping… or harming? Antibiotics for pneumonia with a positive viral panel — do these patients actually benefit? Practical take-homes, real-world night shift scenarios, and what to change on rounds tomorrow. Arti...
• 
  Simple, High-Impact Changes Hospitalists Are Missing (SHM 2026 Takeaways) 08.04.2026 59dk

  With Special Guest Dr. Emily Reams In this special episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Emily Reams to break down the most practice-changing takeaways from SHM Converge 2026. No fluff — just what you can start doing on rounds tomorrow. Topics include: Flu shots in heart failure — real mortality benefit Stopping aspirin in patients on DOACs Anticoagulation in AFib despite fall risk Naltrexone for alcohol use disorder ...
• 
  De-escalating Sepsis Antibiotics & When to Pull the IV (w/ Nicholas Linde, PA) 26.03.2026 39dk

  Episode 5: De-escalating Sepsis Antibiotics & When to Pull the IV w/ Nicholas Linde, PA With Special Guest Nicholas Linde, PA In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist PA Nick Linde to tackle two everyday decisions that impact nearly every inpatient service: De-escalating broad-spectrum antibiotics in sepsis — is it safe to stop vancomycin and zosyn earlier than we think? Routine peripheral IV use — are we leaving IVs in too long and causing harm?...
• 
  Faster Hypernatremia Correction & Long-Acting Antibiotics for Staph Bacteremia (w/ Dr. Kevin Baker) 11.03.2026 34dk

  Episode 4: Faster Hypernatremia Correction & Long-Acting Antibiotics for Staph Bacteremia With Special Guest Dr. Kevin Baker In this episode of Inpatient Update, Dr. Mason Turner is joined by hospitalist Dr. Kevin Baker to discuss two studies that challenge long-held dogma in inpatient medicine: Faster correction of hypernatremia — is the traditional “go slow” rule actually harming patients?Dalbavancin for Staph aureus bacteremia (DOTS Trial) — can two long-acting antibiotic injections re...
• 
  Stop the Aspirin in CAD? Shorter Antibiotics for Bacteremia? (with Dr. Andres Ospina) 25.02.2026 25dk

  In this episode of Inpatient Update, Dr. Mason Turner is joined by Dr. Andres Ospina, fellow hospitalist, to discuss two recent trials with immediate impact on hospital practice: Aspirin plus anticoagulation in chronic coronary disease (AQUATIC Trial) — does keeping aspirin help or harm when long-term anticoagulation is started?Seven vs fourteen days of antibiotics for bloodstream infection (BALANCE Trial) — can we safely cut bacteremia treatment in half?Practical take-homes, clear links to t...
• 
  Pilot Episode 2: Phenobarbital for DTs, Conservative Dialysis for AKI, and Postop Transfusion Thresholds 12.02.2026 28dk

  In Episode 2 of Inpatient Update, your host, Dr. Mason Turner, breaks down three studies that could change what you do on rounds tomorrow: Phenobarbital for alcohol withdrawal — fewer admissions and shorter ED stays during the IV lorazepam shortage natural experiment.Conservative dialysis in AKI requiring RRT (LIBERATE-D) — less routine dialysis, more kidney recovery?Postoperative transfusion thresholds in high–cardiac-risk patients (TOP Trial) — is 7 still enough?Articles & PubMed Links ...
• 
  Pilot Episode: ERCP Antibiotics, Apixaban Dose in Cancer, and Early Beta-Blockers in Cirrhosis 02.02.2026 17dk

  In this pilot episode of Inpatient Update, your host, Dr. Mason Turner, breaks down three clinically relevant studies that could change how you practice tomorrow on the wards: Pre-ERCP antibiotic prophylaxis — does it reduce post-procedure infections in biliary obstruction?Reduced-dose apixaban after 6 months in cancer-associated VTE — noninferior and potentially safer?Early initiation of beta-blockers in cirrhosis with uncomplicated ascites — early signals of benefit.Practical take-homes, cl...